Riskified, CoreWeave, Micron And Other Big Stocks Moving Higher On Wednesday
U.S. stocks mixed; Riskified surged 27.7% on strong Q3 results and raised FY26 guidance. Gevo, Fossil, PepGen and tech stocks also rallied.
Stocks · News reference
Marvell's $115 Billion Lumentum Deal Faces 50-50 Odds: Report
Can Marvell complete its $115 billion Lumentum takeover? Merger specialists see only a 50% chance of success.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
What's Going On With Marvell Technology Stock Wednesday?
Marvell Technology stock surged over 9% Wednesday amid an AI-driven tech rally. See key support levels, analyst targets, and price action.
Marvel Biosciences Announces Expanded Investor Awareness Initiatives
Marvel Biosciences entered into marketing services agreements with Outside The Box Capital Inc. and Investing News Network to increase awareness of its drug development platform.
UBS Maintains Neutral on Lumentum Holdings, Lowers Price Target to $686
Bernstein Maintains Outperform on Lumentum Holdings, Raises Price Target to $700
UBS Adjusts Lumentum Price Target to $686 From $960, Maintains Neutral Rating
UBS has lowered its price target for Lumentum Holdings Inc. to $686 from $960 while maintaining a Neutral rating on the stock.